{
  "html_url": "https://licitia.com.mx/adjudicacion/aa-12-nbr-012nbr001-n-75-2023",
  "canonical": "https://licitia.com.mx/adjudicacion/aa-12-nbr-012nbr001-n-75-2023",
  "id": "77024c6d0e6142418053275d5436f2cd",
  "procedure_number": "AA-12-NBR-012NBR001-N-75-2023",
  "file_number": "E-2023-00066436",
  "title": "ADQUISICIÓN DE MEDICAMENTOS DE PATENTE (114 CLAVES) Y FUENTE UNICA (100 CLAVES)",
  "description": {
    "short": "No existen bienes alternativos o sustitutos, Único Oferente, Derechos exclusivos (patentes, licencias, derechos de autor u otros derechos exclusivos), o por obras de arte.",
    "detailed": "ADQUISICIÓN DE MEDICAMENTOS DE PATENTE (114 CLAVES) Y FUENTE UNICA (100 CLAVES) PARA LOS EJERCICIOS 2023-2024"
  },
  "lifecycle": {
    "section": "concluido",
    "source_status": "ADJUDICADO",
    "moved_at": null
  },
  "buyer": {
    "agency": "IMSS-BIENESTAR",
    "acronym": "IMSS-BIENESTAR",
    "branch": "47 - ENTIDADES NO SECTORIZADAS",
    "buying_unit": "SUBDIRECCION DE RECURSOS MATERIALES",
    "requesting_unit": "unidad requiriente data",
    "requesting_group": "HOSPITAL REGIONAL DE ALTA ESPECIALIDAD DE OAXACA",
    "entity": "TESORERÍA DE LA FEDERACIÓN",
    "unit_slug": "hospital-regional-de-alta-especialidad-de-oaxaca-056ayo940"
  },
  "classification": {
    "procedure_type": "ADJUDICACIÓN DIRECTA",
    "contracting_type": "ADQUISICIONES",
    "publication_type": null,
    "character": "NACIONAL",
    "fiscal_year": 2023,
    "law": "LEY DE ADQUISICIONES, ARRENDAMIENTOS Y SERVICIOS DEL SECTOR PÚBLICO",
    "legal_basis_id": "22",
    "exception_basis": "Art. 41 fr. I",
    "internal_control_number": "AA-012M7B997-E133-2022",
    "supply_source_number": null
  },
  "schedule": {
    "published_at": "2023-07-27T01:54:37.000Z",
    "clarification_meeting_at": null,
    "clarification_questions_deadline_at": null,
    "clarification_responses_deadline_at": null,
    "bid_opening_at": null,
    "award_at": null,
    "estimated_contract_at": "2023-01-02T06:00:00.000Z",
    "site_visit_at": null,
    "estimated_work_start_at": null
  },
  "estimated_value": {
    "minimum": null,
    "maximum": null,
    "currency": "MXN",
    "updated_at": null
  },
  "lots": [
    {
      "number": "1",
      "name": "PARTIDA SOLA",
      "description": "PARTIDA SOLA",
      "requirement_group_id": "1",
      "items": [
        {
          "number": "1",
          "cucop_code": "25301-3515",
          "specific_item_code": "25301",
          "cucop_description": "010.000.6263.00 ATORVASTATINA - EZETIMIBE",
          "description": "ATORVASTATINA/ EZETIMIBA. CÁPSULA O TABLETA. CADA CÁPSULA O TABLETA CONTIENE: ATORVASTATINA CÁLCICA TRIHIDRATO 40.0 MG. Y EZETIMIBA 10.0MG ENVASE CON 30 CÁPSULAS O TABLETAS.",
          "requested_quantity": "60",
          "minimum_quantity": "60",
          "maximum_quantity": "150",
          "unit": "PIEZA",
          "minimum_amount": null,
          "maximum_amount": null
        },
        {
          "number": "2",
          "cucop_code": "25301-3279",
          "specific_item_code": "25301",
          "cucop_description": "010.000.6117.01 INSULINA ASPARTICA (30% DE INSULINA ASPARTA SOLUBLE Y 70% INSULINA ASPARTA CRISTALINA CON PROTAMINA) SUSPENSION INYECTABLE CADA ML CONTIENE: INSULINA ASPARTA DE ORIGEN ADN RECOMBINANTE (30% DE INSULINA ASPARTA SOLUBLE Y 70% DE INSULINA ASPARTA CRISTALINA CON PROTAMINA) 100 U ENVASE CON 5 PLUMAS PRELLENADAS CADA UNA CON 3 ML (100 U/ML).",
          "description": "INSULINA ASPARTA/INSULINA ASPARTA PROTAMINA. SUSPENSIÓN INYECTABLE CADA ML CONTIENE: INSULINA ASPARTA DE ORIGEN ADN RECOMBINANTE (30% DE INSULINA ASPARTA SOLUBLE Y 70% DE INSULINA ASPARTA PROTAMINA CRISTALINA) 100 U. ENVASE O CAJA DE CARTÓN CON 5 PLUMAS PRELLENADAS O PRECARGADAS CON 3 ML (100 U/ML).",
          "requested_quantity": "128",
          "minimum_quantity": "128",
          "maximum_quantity": "320",
          "unit": "PIEZA",
          "minimum_amount": null,
          "maximum_amount": null
        },
        {
          "number": "3",
          "cucop_code": "25301-3515",
          "specific_item_code": "25301",
          "cucop_description": "010.000.6263.00 ATORVASTATINA - EZETIMIBE",
          "description": "ATORVASTATINA/ EZETIMIBA. CÁPSULA O TABLETA. CADA CÁPSULA O TABLETA CONTIENE: ATORVASTATINA CÁLCICA TRIHIDRATO 40.0 MG. Y EZETIMIBA 10.0MG ENVASE CON 30 CÁPSULAS O TABLETAS.",
          "requested_quantity": "48",
          "minimum_quantity": "48",
          "maximum_quantity": "120",
          "unit": "PIEZA",
          "minimum_amount": null,
          "maximum_amount": null
        }
      ]
    }
  ],
  "awards": [
    {
      "id": "C-2023-00081204",
      "internal_reference": "HRAEO-AD-B-C-032/2023",
      "title": "ADQUISICIÓN DE MEDICAMENTOS DE PATENTE (114 CLAVES) Y FUENTE UNICA (100 CLAVES)",
      "status": "PUBLICADO",
      "contractor": {
        "name": "NOVO NORDISK MEXICO SA DE CV",
        "normalized_name": "NOVO NORDISK MEXICO",
        "rfc_type": null,
        "slug": "novo-nordisk-mexico"
      },
      "contract_period": {
        "published_at": "2023-07-27T01:57:53.000Z",
        "starts_at": "2023-01-02T06:00:00.000Z",
        "ends_at": "2024-12-31T06:00:00.000Z"
      },
      "value": {
        "subtotal": "75840",
        "tax": "0",
        "total": "75840",
        "maximum_subtotal": "189600",
        "maximum_total": "189600",
        "currency": "MXN"
      },
      "open_contract_type": null,
      "quantity": null,
      "exercised_quantity": null,
      "participants": [],
      "line_items": [
        {
          "number": "0",
          "cucop_code": "25301-3279",
          "description": "INSULINA ASPARTA/INSULINA ASPARTA PROTAMINA. SUSPENSIÓN INYECTABLE CADA ML CONTIENE: INSULINA ASPARTA DE ORIGEN ADN RECOMBINANTE (30% DE INSULINA ASPARTA SOLUBLE Y 70% DE INSULINA ASPARTA PROTAMINA CRISTALINA) 100 U. ENVASE O CAJA DE CARTÓN CON 5 PLUMAS PRELLENADAS O PRECARGADAS CON 3 ML (100 U/ML).",
          "unit": "PIEZA",
          "requested_quantity": "128",
          "awarded_quantity": null,
          "unit_price": "592.5",
          "subtotal": "75840",
          "tax": null,
          "other_taxes": null,
          "total": "75840"
        }
      ]
    },
    {
      "id": "C-2023-00081201",
      "internal_reference": "HRAEO-AD-B-C-033/2023",
      "title": "ADQUISICIÓN DE MEDICAMENTOS DE PATENTE (114 CLAVES) Y FUENTE UNICA (100 CLAVES)",
      "status": "PUBLICADO",
      "contractor": {
        "name": "ORGANON COMERCIALIZADORA S DE RL DE CV",
        "normalized_name": "ORGANON COMERCIALIZADORA",
        "rfc_type": null,
        "slug": "organon-comercializadora"
      },
      "contract_period": {
        "published_at": "2023-07-27T01:54:37.000Z",
        "starts_at": "2023-01-02T06:00:00.000Z",
        "ends_at": "2024-12-31T06:00:00.000Z"
      },
      "value": {
        "subtotal": "36720",
        "tax": "0",
        "total": "36720",
        "maximum_subtotal": "91800",
        "maximum_total": "91800",
        "currency": "MXN"
      },
      "open_contract_type": null,
      "quantity": null,
      "exercised_quantity": null,
      "participants": [],
      "line_items": [
        {
          "number": "0",
          "cucop_code": "25301-3515",
          "description": "ATORVASTATINA/ EZETIMIBA. CÁPSULA O TABLETA. CADA CÁPSULA O TABLETA CONTIENE: ATORVASTATINA CÁLCICA TRIHIDRATO 40.0 MG. Y EZETIMIBA 10.0MG ENVASE CON 30 CÁPSULAS O TABLETAS.",
          "unit": "PIEZA",
          "requested_quantity": "60",
          "awarded_quantity": null,
          "unit_price": "340",
          "subtotal": "20400",
          "tax": null,
          "other_taxes": null,
          "total": "20400"
        },
        {
          "number": "0",
          "cucop_code": "25301-3515",
          "description": "ATORVASTATINA/ EZETIMIBA. CÁPSULA O TABLETA. CADA CÁPSULA O TABLETA CONTIENE: ATORVASTATINA CÁLCICA TRIHIDRATO 40.0 MG. Y EZETIMIBA 10.0MG ENVASE CON 30 CÁPSULAS O TABLETAS.",
          "unit": "PIEZA",
          "requested_quantity": "48",
          "awarded_quantity": null,
          "unit_price": "340",
          "subtotal": "16320",
          "tax": null,
          "other_taxes": null,
          "total": "16320"
        }
      ]
    }
  ],
  "documents": [
    {
      "id": null,
      "annex_number": 1,
      "document_type": null,
      "description": "JUSTIFICACIÓN DE EXCEPCIÓN",
      "filename": "Justificación Caas 114-100.pdf",
      "availability": "available",
      "size_bytes": "37888100",
      "mime_type": "application/pdf",
      "sha256": null,
      "uploaded_at": "2025-12-07T19:54:38.898Z",
      "updated_at": "2025-12-07T19:54:38.900Z"
    },
    {
      "id": null,
      "annex_number": 1,
      "document_type": null,
      "description": "ANEXO TÉCNICO",
      "filename": "1_ANEXO TÿCNICO.PDF",
      "availability": "available",
      "size_bytes": "36430962",
      "mime_type": "application/pdf",
      "sha256": null,
      "uploaded_at": "2025-12-07T19:54:50.889Z",
      "updated_at": "2025-12-07T19:54:50.890Z"
    },
    {
      "id": null,
      "annex_number": 6,
      "document_type": null,
      "description": "OFICIO DE ADJUDICACIÓN",
      "filename": "Organon eco_12012022221449.PDF",
      "availability": "available",
      "size_bytes": "318465",
      "mime_type": "application/pdf",
      "sha256": null,
      "uploaded_at": "2025-12-07T19:54:52.085Z",
      "updated_at": "2025-12-07T19:54:52.086Z"
    },
    {
      "id": null,
      "annex_number": 7,
      "document_type": null,
      "description": "OFICIO DE ADJUDICACIÓN",
      "filename": "Novo nordisk_12022022005211.PDF",
      "availability": "available",
      "size_bytes": "109781",
      "mime_type": "application/pdf",
      "sha256": null,
      "uploaded_at": "2025-12-07T19:54:53.744Z",
      "updated_at": "2025-12-07T19:54:53.745Z"
    }
  ],
  "alternates": [],
  "similar": [
    {
      "numero_procedimiento": "aa-50-gyr-050gyr015-t-142-2023",
      "nombre_procedimiento": "AA-50-GYR-050GYR015-T-142-2023 ADQ PARA CONTRATACIÓN 010 MEDICAMNETO PAC 0041",
      "dependencia": "IMSS",
      "siglas": "IMSS",
      "score": 0.11791185598777087
    },
    {
      "numero_procedimiento": "aa-50-gyr-050gyr003-t-119-2023",
      "nombre_procedimiento": "ADQUISICION DE 2 CLAVES PERTENENCIENTES AL GRUPO DE MEDICINAS",
      "dependencia": "IMSS",
      "siglas": "IMSS",
      "score": 0.1285377557758436
    },
    {
      "numero_procedimiento": "aa-50-gyr-050gyr030-n-253-2023",
      "nombre_procedimiento": "AA - N-253- 2023 - ADQUISICION DE MEDICAMENTO Y ESTUPEFACIENTES/PSICOTROPICOS",
      "dependencia": "IMSS",
      "siglas": "IMSS",
      "score": 0.13300011751056418
    },
    {
      "numero_procedimiento": "aa-50-gyr-050gyr030-n-343-2023",
      "nombre_procedimiento": "AA - N-343- 2023 - ADQUISICION DE MEDICAMENTO Y ESTUPEFACIENTES/PSICOTROPICOS",
      "dependencia": "INSTITUTO MEXICANO DEL SEGURO SOCIAL",
      "siglas": "IMSS",
      "score": 0.13303611078965027
    },
    {
      "numero_procedimiento": "aa-50-gyr-050gyr057-t-186-2023",
      "nombre_procedimiento": "ADQUISICIÓN DE MEDICAMENTO GPO 010",
      "dependencia": "INSTITUTO MEXICANO DEL SEGURO SOCIAL",
      "siglas": "IMSS",
      "score": 0.13792590539984706
    },
    {
      "numero_procedimiento": "aa-50-gyr-050gyr041-t-420-2023",
      "nombre_procedimiento": "ADQUISICIÓN DE MEDICAMENTO",
      "dependencia": "INSTITUTO MEXICANO DEL SEGURO SOCIAL",
      "siglas": "IMSS",
      "score": 0.13905434063562472
    }
  ]
}